U.S. Markets close in 5 hrs 31 mins

Sequenom (SQNM) Soars: Stock Rises 6.4%

Zacks Equity Research

Sequenom Inc. (SQNM) was a big mover last session, as its shares rose over 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the trend for the healthcare company since Feb 28, as the stock is now trading above the volatile price range of $2.29 to $2.39.

In the last 30-day frame, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Sequenom currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Other better-ranked stocks in the medical sector include Cambrex Corporation. (CBM), Alkermes plc (ALKS) and Alexion Pharmaceuticals, Inc. (ALXN). While Alexion and Alkermes sport a Zacks Rank #1 (Strong Buy), Cambrex carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

SEQUENOM INC (SQNM): Free Stock Analysis Report

CAMBREX CORP (CBM): Free Stock Analysis Report

ALKERMES PLC ORD (ALKS): Free Stock Analysis Report


Zacks Investment Research